Brand Intelligence Graph
Company Overview
About Microbiotica
Microbiotica applies genomics and machine learning to map the gut microbiome's causal role in disease, then develops live biotherapeutic products (LBPs) targeting the specific bacterial strains responsible. The company's Reference Microbiome database — built from thousands of patient samples — is the world's most comprehensive catalog of gut bacteria linked to disease outcomes, providing a systematic foundation for microbiome drug discovery.
Business Model & Competitive Advantage
Spun out of the Wellcome Sanger Institute in 2017, Microbiotica has demonstrated that specific microbiome compositions predict and mediate response to cancer immunotherapy (checkpoint inhibitors). Its lead programs aim to convert non-responders into responders by supplementing their microbiome with beneficial bacterial strains. Phase 1/2 trials in combination with anti-PD1 therapies are underway.
Competitive Landscape 2025–2026
The $105M Series C in 2025 will fund clinical advancement of Microbiotica's oncology and inflammatory bowel disease (IBD) programs. As the microbiome field matures from correlation to causation, Microbiotica's database advantage and clinical momentum position it as a leader in what could become a multi-billion dollar therapeutic category.
Key Differentiators
Emerging Innovator
Microbiotica is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Finch Therapeutics
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Compare Microbiotica with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Microbiotica? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Microbiotica Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Microbiotica vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →